巨噬细胞移动抑制因子
蛋白质稳态
纤维化
特发性肺纤维化
肺纤维化
肺
癌症研究
肺泡巨噬细胞
支气管肺泡灌洗
免疫学
转基因小鼠
趋化因子
肌成纤维细胞
成纤维细胞
转化生长因子
SMAD公司
巨噬细胞
受体
医学
化学
信号转导
细胞生物学
生物
离体
趋化因子受体
转基因
细胞
炎症
下调和上调
细胞因子
CXCL1型
体内
转化生长因子β
病理
作者
Sang‐Hun Kim,Jessica Nouws,Jannik Ruwisch,Gavitt A. Woodard,Joseph Cooley,Johad Khoury,Huanxing Sun,Edward Doherty,Marta Piecychna,Edward P. Manning,Min‐Jong Kang,Emanuela M. Bruscia,Huanhuan Wei,Y. Zhang,Timur O. Yarovinsky,John Hwa,William J. Zacharias,Jennifer L. Ingram,Chun Geun Lee,Jack A. Elias
标识
DOI:10.1126/scitranslmed.adr2277
摘要
) transgenic mouse models and in ex vivo human precision-cut lung slices treated with fibrotic cocktail. In study participants with IPF, BALF MIF was elevated compared with that in study participants without IPF. In participants with IPF, BALF MIF greater than 4000 picograms per milliliter was associated with increased mortality compared with participants with IPF with lower MIF. Together, these findings define a UPS-sensitive epithelial-macrophage signaling connection and identify MIF-CD74 cross-talk as a potential therapeutic target in fibrotic lung disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI